These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31101050)

  • 1. AIBP and APOA-I synergistically inhibit intestinal tumor growth and metastasis by promoting cholesterol efflux.
    Zhang T; Wang Q; Wang Y; Wang J; Su Y; Wang F; Wang G
    J Transl Med; 2019 May; 17(1):161. PubMed ID: 31101050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein A-1 binding protein promotes macrophage cholesterol efflux by facilitating apolipoprotein A-1 binding to ABCA1 and preventing ABCA1 degradation.
    Zhang M; Li L; Xie W; Wu JF; Yao F; Tan YL; Xia XD; Liu XY; Liu D; Lan G; Zeng MY; Gong D; Cheng HP; Huang C; Zhao ZW; Zheng XL; Tang CK
    Atherosclerosis; 2016 May; 248():149-59. PubMed ID: 27017521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of angiogenesis by AIBP-mediated cholesterol efflux.
    Fang L; Choi SH; Baek JS; Liu C; Almazan F; Ulrich F; Wiesner P; Taleb A; Deer E; Pattison J; Torres-Vázquez J; Li AC; Miller YI
    Nature; 2013 Jun; 498(7452):118-22. PubMed ID: 23719382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AIBP augments cholesterol efflux from alveolar macrophages to surfactant and reduces acute lung inflammation.
    Choi SH; Wallace AM; Schneider DA; Burg E; Kim J; Alekseeva E; Ubags ND; Cool CD; Fang L; Suratt BT; Miller YI
    JCI Insight; 2018 Aug; 3(16):. PubMed ID: 30135304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesterol Efflux-Independent Modification of Lipid Rafts by AIBP (Apolipoprotein A-I Binding Protein).
    Low H; Mukhamedova N; Capettini LDSA; Xia Y; Carmichael I; Cody SH; Huynh K; Ditiatkovski M; Ohkawa R; Bukrinsky M; Meikle PJ; Choi SH; Field S; Miller YI; Sviridov D
    Arterioscler Thromb Vasc Biol; 2020 Oct; 40(10):2346-2359. PubMed ID: 32787522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic metabolite profiling reveals sexual dimorphism of AIBP control of metabolism in mice.
    Kim JD; Zhu L; Sun Q; Fang L
    PLoS One; 2021; 16(4):e0248964. PubMed ID: 33793635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein A-1 Binding Protein Inhibits Inflammatory Signaling Pathways by Binding to Apolipoprotein A-1 in THP-1 Macrophages.
    Zhang M; Zhao GJ; Yin K; Xia XD; Gong D; Zhao ZW; Chen LY; Zheng XL; Tang XE; Tang CK
    Circ J; 2018 Apr; 82(5):1396-1404. PubMed ID: 29618705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AIBP reduces atherosclerosis by promoting reverse cholesterol transport and ameliorating inflammation in apoE
    Zhang M; Zhao GJ; Yao F; Xia XD; Gong D; Zhao ZW; Chen LY; Zheng XL; Tang XE; Tang CK
    Atherosclerosis; 2018 Jun; 273():122-130. PubMed ID: 29555084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein A-I Binding Protein Inhibits the Formation of Infantile Hemangioma through Cholesterol-Regulated Hypoxia-Inducible Factor 1α Activation.
    Jiang Y; Li X; Liu Q; Lei G; Wu C; Chen L; Zhao Y; Hu Y; Xian H; Mao R
    J Invest Dermatol; 2024 Mar; 144(3):645-658.e7. PubMed ID: 37832842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AIBP protects against metabolic abnormalities and atherosclerosis.
    Schneider DA; Choi SH; Agatisa-Boyle C; Zhu L; Kim J; Pattison J; Sears DD; Gordts PLSM; Fang L; Miller YI
    J Lipid Res; 2018 May; 59(5):854-863. PubMed ID: 29559522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular AIBP (Apolipoprotein A-I Binding Protein) Regulates Oxidized LDL (Low-Density Lipoprotein)-Induced Mitophagy in Macrophages.
    Choi SH; Agatisa-Boyle C; Gonen A; Kim A; Kim J; Alekseeva E; Tsimikas S; Miller YI
    Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):e82-e96. PubMed ID: 33356389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AIBP, Angiogenesis, Hematopoiesis, and Atherogenesis.
    Qiu X; Luo J; Fang L
    Curr Atheroscler Rep; 2020 Nov; 23(1):1. PubMed ID: 33230630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AIBP Limits Angiogenesis Through γ-Secretase-Mediated Upregulation of Notch Signaling.
    Mao R; Meng S; Gu Q; Araujo-Gutierrez R; Kumar S; Yan Q; Almazan F; Youker KA; Fu Y; Pownall HJ; Cooke JP; Miller YI; Fang L
    Circ Res; 2017 May; 120(11):1727-1739. PubMed ID: 28325782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of apolipoprotein-A-I/apolipoprotein-A-I binding protein and anti-VEGF treatment overcomes anti-VEGF resistance in choroidal neovascularization in mice.
    Zhu L; Parker M; Enemchukwu N; Shen M; Zhang G; Yan Q; Handa JT; Fang L; Fu Y
    Commun Biol; 2020 Jul; 3(1):386. PubMed ID: 32678293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AIBP: A Novel Molecule at the Interface of Cholesterol Transport, Angiogenesis, and Atherosclerosis.
    Zhu L; Fang L
    Methodist Debakey Cardiovasc J; 2015; 11(3):160-5. PubMed ID: 26634023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HDL and ApoA-I inhibit antigen presentation-mediated T cell activation by disrupting lipid rafts in antigen presenting cells.
    Wang SH; Yuan SG; Peng DQ; Zhao SP
    Atherosclerosis; 2012 Nov; 225(1):105-14. PubMed ID: 22862966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of lipid rafts, angiogenesis and inflammation by AIBP.
    Fang L; Miller YI
    Curr Opin Lipidol; 2019 Jun; 30(3):218-223. PubMed ID: 30985364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a sequence of apolipoprotein A-I associated with the efflux of intracellular cholesterol to human serum and apolipoprotein A-I containing particles.
    Sviridov D; Pyle L; Fidge N
    Biochemistry; 1996 Jan; 35(1):189-96. PubMed ID: 8555173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein A-I (R151C)Paris is defective in activation of lecithin: cholesterol acyltransferase but not in initial lipid binding, formation of reconstituted lipoproteins, or promotion of cholesterol efflux.
    Daum U; Langer C; Duverger N; Emmanuel F; Benoit P; Denèfle P; Chirazi A; Cullen P; Pritchard PH; Bruckert E; Assmann G; von Eckardstein A
    J Mol Med (Berl); 1999 Aug; 77(8):614-22. PubMed ID: 10543393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinase 8 degrades apolipoprotein A-I and reduces its cholesterol efflux capacity.
    Salminen A; Åström P; Metso J; Soliymani R; Salo T; Jauhiainen M; Pussinen PJ; Sorsa T
    FASEB J; 2015 Apr; 29(4):1435-45. PubMed ID: 25550459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.